General Manager's Words

Corporate Vision: Building Asia's Flagship Specialty Pharma
Orient Pharma (OP) vision is to become Asia's benchmark specialty Pharma, focusing on the development of 505(b)(2) new drugs and global market expansion. The company's core philosophy is built on three core values: integrity, consensus building and execution, and the pursuit of superior value differentiation, reflecting a high commitment to customers, partners, and colleagues. Adhering to this spirit, Orient Pharma (OP) is committed to building vertically integrated core capabilities in R&D, manufacturing, and marketing. With Taiwan as its R&D and manufacturing base, it solidifies its position in the local medical market while expanding into international markets such as the United States, Southeast Asia, and Australia, gradually realizing a global footprint.

Strategic Core: Market-Driven R&D
Orient Pharma (OP) adopts a market-driven R&D strategy. Its business development team integrates market analysis, competitive assessment, and epidemiological research capabilities, focusing on unmet medical needs with potential market value as the core basis for product development. Through close collaboration between the business and R&D teams, the company ensures that R&D results have clinical applicability and market potential, strengthening the strategic positioning and commercial effectiveness of its product lines. 

Technology Platform: Three Core Drivers of Innovation
Orient Pharma (OP) focuses on applying three core multi-level drug delivery technology platforms: Semi-Solid Multilayer Drug Release Technology (SMRT), Multi-Unit Sphere System Technology (MUPS), and Osmotic Pressure Controlled Release Technology (OROS). These platforms are used to design 505(b)(2) new drugs for new indications, dosage forms, combination therapies, and dosages. These technologies not only offer advantages such as shorter development timelines and relatively lower development costs, but also enhance drug efficacy stability and patient compliance, becoming the technological pillars of Orient Pharma (OP) product development.

Commercial Advantages: Efficient Development and Patent Protection
The 505(b)(2) development pathway allows Orient Pharma (OP) to utilize existing literature and clinical evidence, simplifying clinical trial procedures, reducing development costs, and effectively shortening the time from drug approval to market launch in the US and Taiwan. The market exclusivity periods granted by the US FDA to different categories of new drugs further guarantee market space in the early stages of product launch. Orient Pharma (OP) also actively pursues a patent strategy, applying for patent protection for its research results to enhance the added value of its technology and its global competitiveness.

Management Philosophy: Systematic Management and Talent Development
In organizational management, Orient Pharma (OP) emphasizes the soundness of logic, systems, and organizational structures, stressing hierarchical responsibility and professional division of labor, practicing "selecting the right people, placing them in the right positions, and doing the right things." The company continuously cultivates professional, efficient, and resilient R&D and business teams through institutionalized talent development, teamwork, and creative integration, making the "never give up" and "continuous improvement" spirit of its corporate culture the core driving force for growth and innovation.